Saturated Fat: Part of a Healthy Diet
- 789 Downloads
Purpose of Review
Despite the American public following recommendations to decrease absolute dietary fat intake and specifically decrease saturated fat intake, we have seen a dramatic rise over the past 40 years in the rates of non-communicable diseases associated with obesity and overweight, namely cardiovascular disease. The development of the diet-heart hypothesis in the mid twentieth century led to faulty but long-held beliefs that dietary intake of saturated fat led to heart disease. Saturated fat can lead to increased LDL cholesterol levels, and elevated plasma cholesterol levels have been shown to be a risk factor for cardiovascular disease; however, the correlative nature of their association does not assign causation.
Advances in understanding the role of various lipoprotein particles and their atherogenic risk have been helpful for understanding how different dietary components may impact CVD risk. Numerous meta-analyses and systematic reviews of both the historical and current literature reveals that the diet-heart hypothesis was not, and still is not, supported by the evidence. There appears to be no consistent benefit to all-cause or CVD mortality from the reduction of dietary saturated fat. Further, saturated fat has been shown in some cases to have an inverse relationship with obesity-related type 2 diabetes.
Rather than focus on a single nutrient, the overall diet quality and elimination of processed foods, including simple carbohydrates, would likely do more to improve CVD and overall health. It is in the best interest of the American public to clarify dietary guidelines to recognize that dietary saturated fat is not the villain we once thought it was.
KeywordsSaturated fat SFA Fatty acids Dietary fat Triglycerides PUFA LDL cholesterol Diet Cardiovascular disease CVD Atherosclerosis Diet-heart hypothesis Dietary guidelines
I wish to acknowledge the guidance provided by Dr. Charlene Compher and thank her for critical analysis and feedback on the manuscript. Additionally, I am particularly grateful for the editing assistance from Candi Parks Gershuni.
Compliance with Ethical Standards
Conflict of Interest
Victoria M. Gershuni declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.Rowland I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2017.Google Scholar
- 10.•• de Souza RJ, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. Great review on the lack of evidence to support an association between SFA intake and the incidence of cardiovascular disease or diabetes. PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2014;2:810–8.PubMedPubMedCentralCrossRefGoogle Scholar
- 14.Praagman J, Beulens JWJ, Alssema M, Zock PL, Wanders AJ, Sluijs I, et al. The association between dietary saturated fatty acids and ischemic heart disease depends on the type and source of fatty acid in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Am J Clin Nutr. 2016;103:356–65.PubMedCrossRefGoogle Scholar
- 23.Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113:2062–70.PubMedCrossRefGoogle Scholar
- 24.Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, et al. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013;62:1580–4.PubMedCrossRefGoogle Scholar
- 27.Camont L, Lhomme M, Rached F, le Goff W, Negre-Salvayre A, Salvayre R, et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol. 2013;33:2715–23.PubMedCrossRefGoogle Scholar
- 38.Dietary goals for the United States: statement of The American Medical Association to the Select Committee on Nutrition and Human Needs, United States Senate. R I Med J. 1977;60, 576–581.Google Scholar
- 40.Kochanek KD, Murphy S, Xu J & Arias E. Mortality in the United States, 2016. NCHS Data Brief. 2017;1–8.Google Scholar
- 56.Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.PubMedPubMedCentralCrossRefGoogle Scholar
- 61.Estruch R, et al. Retraction and republication: primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013. 2018;368:1279–90. N Engl J MedGoogle Scholar
- 68.•• Harcombe Z, Baker JS, DiNicolantonio JJ, Grace F, Davies B. Evidence from randomised controlled trials does not support current dietary fat guidelines: a systematic review and meta-analysis. Open Heart. 2016;3:e000409. Excellent review showing that the current dietary guidelines to restrict dietary fat are not evidence based and adherence to these guidelines have not improved outcomes. Nice accompaniment to previous review showing that the original dietary guidelines were not evidence based either. PubMedPubMedCentralCrossRefGoogle Scholar
- 69.• Hamley S. The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutr J. 2017;16(30):30. Meta-analysis of available evidence from RCTs evaluating effect of replacing SFA with n-6 PUFA on CHD events, CHD mortality, and total mortality. Reveals that recommendations to replace SFA to n-6 PUFA (vegetable oils) are not supported by the literature. PubMedPubMedCentralCrossRefGoogle Scholar
- 70.Hooper L, Martin N, Abdelhamid A & Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;CD011737.Google Scholar
- 71.Harcombe Z, Baker JS, Cooper SM, Davies B, Sculthorpe N, DiNicolantonio JJ, et al. Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis. Open Heart. 2015;2:e000196.PubMedPubMedCentralCrossRefGoogle Scholar